Enveric Biosciences Inc. (ENVB)
Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution
GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
Iovance Biotherapeutics to Present at Upcoming Conference
MAIA Biotechnology to Present at BIO International Convention 2025
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology